This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BIO-Europe Lead Retrieval
November 3–5, 2025
Vienna Congress and Convention Center, Vienna, AustriaNovember 11–12, 2025 | Digital Partnering

Samuel Black
Director Business Development at Merck
Speaker

Profile

Sam Black is a Business Development & Licensing professional at Merck with 8+ years of life sciences experience in Europe, APAC and the US. He has executed numerous transactions, leading international, cross-functional, project teams on negotiations primarily across oncology, immuno-oncology, neurology, and immunology. He has broad experience across deal types and structures (e.g. in and out-licensing of assets and technologies, collaboration agreements, option agreements, asset acquisitions, academic partnerships, combination agreements, and companion diagnostic agreements) including corporate components of such transactions (e.g.: equity considerations), up to deal values of $2B+. Sam holds a MPhil in Bioscience Enterprise from the University of Cambridge and a MEng in Biochemical Engineering with Management from University College London.

Agenda Sessions

  • Brewing innovation: The next wave of therapeutic modalities and technologies

    13:30